Viviane Monges - 17 Mar 2026 Form 3 Insider Report for Pharvaris N.V. (PHVS)

Role
Director
Signature
/s/ Marnus Nel, Attorney-in-Fact for Vivian Monges
Issuer symbol
PHVS
Transactions as of
17 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 14:23:22 UTC
Previous filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Monges Viviane Director 1 CRANBERRY HILL SUITE 400, LEXINGTON /s/ Marnus Nel, Attorney-in-Fact for Vivian Monges 18 Mar 2026 0001838204

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PHVS Common Stock 14,654 17 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PHVS Stock Option (Right to Buy) 17 Mar 2026 Common Stock 16,500 $28.00 Direct F2
holding PHVS Stock Option (Right to Buy) 17 Mar 2026 Common Stock 15,000 $16.05 Direct F2
holding PHVS Stock Option (Right to Buy) 17 Mar 2026 Common Stock 14,000 $22.31 Direct F2
holding PHVS Stock Option (Right to Buy) 17 Mar 2026 Common Stock 21,000 $8.05 Direct F3
holding PHVS Stock Option (Right to Buy) 17 Mar 2026 Common Stock 17,500 $18.14 Direct F4
holding PHVS Stock Option (Right to Buy) 17 Mar 2026 Common Stock 35,000 $17.43 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units previously granted under the Company's equity plan that remain outstanding as of March 18, 2026. The awards settle in shares of common stock and are reported in Table I as non-derivative securities. Vesting occurs as follows: -5,500 RSUs from an award granted March 3, 2026 of which 100% will vest March 3, 2027.
F2 100% of the option vest on the 12-month anniversary.
F3 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
F4 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.
F5 25% of the option vested on July 1, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.